Founded in 1980, Herbalife Ltd. (HLF) is a global nutrition company that develops and sells weight management, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, and personal care products. With headquarters in Los Angeles, California, its products are marketed in over 90 countries worldwide through a network of approximately 2.3 million independent distributors, some of whom earn a profit on product sales and additional commission from a multi-level marketing (MLM) compensation structure.
Herbalife Ltd. is dedicated to improving nutritional habits around the world with its varied range of products, often customized based on regional tastes and dietary preferences. At the heart of its operations, the company aims to help people pursue a healthy, active life supported by good nutrition. The company sells protein shakes, protein snacks, nutrition, energy and fitness supplements, and personal care products.
Herbalife’s revenue primarily comes from five regions: Asia Pacific; North America; Mexico; South and Central America; and EMEA (Europe, the Middle East, and Africa). The company’s wide range of products has been developed to assist customers in achieving their health goals, whether they want to lose weight, get in shape or improve their overall wellness.
However, the company has been subject to criticism and multiple lawsuits due to its network marketing business model, commonly classified as a pyramid scheme. Herbalife Ltd. disagrees with this classification and maintains that the business model is legal. In 2016, the FTC mandated Herbalife to restructure its U.S. business operations and pay $200 million for consumer redress in response to accusations of unfair and deceptive practices.
Additionally, Herbalife supports the Herbalife Nutrition Foundation (HNF) and its Casa Herbalife programs to help bring good nutrition to children in need. The company also sponsors more than 190 world-class athletes, teams, and events around the globe, including Cristiano Ronaldo, the LA Galaxy, and numerous Olympic teams.
Despite its controversies, Herbalife Ltd. has remained a key player in the global nutrition and supplement industry. The company prides itself on its commitment to quality, scientific research that backs up its products, and its strategic approach to nutrition that helps customers manage weight, enhance fitness, and improve their overall health.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends

Wall Street Zen downgraded Herbalife (NYSE:HLF) from a "Buy" to a "Hold" rating. Despite this downgrade, the average analyst consensus remains a "Moderate Buy" with a $17.67 price target. The company recently reported quarterly revenue of $1.33 billion, exceeding expectations, but missed earnings per share estimates.

Herbalife has authorized a new multi-year share repurchase program and is expanding its focus on personalized nutrition and technology-enabled offerings. The company recently completed a refinancing transaction to reduce annual cash interest expense and reported continued net sales growth. These initiatives are part of a broader capital allocation strategy alongside ongoing operational developments.

Corient Private Wealth LP significantly increased its stake in Herbalife Ltd (NYSE:HLF) by 697.8% during the second quarter, bringing its total ownership to 179,125 shares valued at $2.36 million. This move is part of a broader trend of institutional investors adjusting their positions in the company, despite Herbalife missing its recent EPS consensus estimate while exceeding revenue expectations. Analysts currently rate Herbalife as a "Moderate Buy" with an average target price of $17.67, and the company has authorized a $250 million share buyback program.

Herbalife (HLF) has announced a new capital plan, including a share repurchase program of up to $250 million over three years. Despite recent modest share price gains, the stock is still down year-to-date, though it has seen a significant total shareholder return over the past year. The market perceives Herbalife as 28% undervalued, trading at $12.23 against a fair value of $17, but the company faces challenges with flat to declining volumes in several regions and reliance on network recruiting.

Analysts have assigned Herbalife Ltd (NYSE:HLF) a "Moderate Buy" consensus rating, with an average 12-month price target of $17.67, significantly higher than its current share price of $11.93. Despite mixed Q2 results where revenue beat estimates but EPS fell short, the company authorized a $250 million share-repurchase program, indicating confidence from its board. Several institutional investors also increased their holdings in the company during the second quarter.

Texas Capital has upgraded Herbalife (NYSE:HLF) to a "strong-buy" rating, with Wall Street Zen also raising its rating to "buy." MarketBeat analysts maintain a "Moderate Buy" consensus with an average price target of $17.67. Herbalife recently authorized a $250 million share-repurchase program and reported a 5.4% year-over-year revenue increase, although EPS fell short of expectations.
Herbalife (HLF) has announced a new $250 million share buyback program over the next three years, signaling management's confidence despite the stock trading in single digits and a battered balance sheet. While the company reported four consecutive quarters of sales growth and strong free cash flow, it also recorded a net loss and faces concerns regarding its balance sheet, leadership changes, and a high short interest. The buyback aims to capitalize on what management sees as an undervalued stock, while the market remains skeptical.
Herbalife's board has approved a new $250 million share buyback program, to be executed over the next three years, signaling confidence from management despite the stock trading in single digits and a battered balance sheet. The company reported its fourth consecutive quarter of year-over-year sales expansion, with strong growth in Latin America and Asia Pacific, but also noted a net loss and declining sales in China and EMEA. Despite management's optimism, the market remains skeptical, as evidenced by declining hedge fund ownership, high short interest, and a low forward P/E ratio.

Virginia Retirement Systems acquired 104,350 shares of Herbalife Ltd. (NYSE:HLF) valued at approximately $1.37 million, representing about 0.10% of the company, with several other institutional investors also increasing their positions. Herbalife shares opened at $12.00, down 2.3%, after reporting quarterly EPS of $0.51, missing estimates, despite a 5.4% year-over-year revenue increase to $1.33 billion. The company's board authorized a $250 million share buyback program, and analysts maintain a consensus "Hold" rating with an average price target of $17.00.